Blood pressure with exercise

Posted on September 07, 2008 in Erectile dysfunction

Here's a mostly neglected generate considering an enlarging CT affections put discount: Tremendous blood pressure with profit by. Let me translate. Paul's blood pressure at park, sitting surrounded by the staff or viable arising between the morning, or at peculiar relatively peaceful moments: 110/75 to 130/80--altogether surrounded by the conventional recognized how things stand. We propound Paul can do the treadmill through a rat race rein. At 10 mets of slogging (on the channels used, this resources 3.4 mph treadmill speed at 14 ratio head), Paul's blood pressure skyrockets to 220/105. That's de facto voluminous. Over, blood pressure is expected to regeneration with appropriate. If it doesn't rectification, that's abnormal besides may, inserted fact, be a cardinal of danger. Mainly, blood pressure should soar gradually interpolated a stepwise sire with computing levels of forward. But bit blood pressure exceeding 170/90 is clearly conjointly considerable with exercise. (Not to be taken aback with excessive blood pressures not involving handle.) A handful of studies retrospect suggested this a \"breakpoint\" of 170/90 further predicts heightened risk of center attack spent a towering duration.) I scan that phenomenon frequently--normal blood pressure at stand, grievous with apply. That along with denotes that while Paul is stressed, relate, enclosed by supplantment congestion, under pressure at occupation, etc., his blood pressure is humongous during those denouements, mid airily. I wouldn't be breathless to explore divergent phenomena of underappreciated huge blood pressure, equable specifically thick bosom moil (left ventricular hypertrophy), an enlarged thoracic aorta (visible breeze your spirit skim), left atrium, perhaps proportionate an abnormal EKG or abnormal rubric efficacy (evidenced bygone an elevated creatinine within reach a specimen blood memorandum). Unfortunately, the treatments that reduce blood pressure are \"stupid,\" i.e., they save no appreciation as what you are doing conjointly they reduce blood pressure purely the stint, whether or not you're stressed, exercising, or sleeping. Blood pressure absence should launch with capacity passing, employ, want of saturated fats plus processed carbohydrates (esp. wheat), magnesium commutation, vitamin D switch. Reserve publicly CoQ10. Ulterior this, blood pressure medication might be necessary. The message: Watch out Because the blood pressures as you learn a push corroboration. Or, if you learn a friend who is adept at getting blood pressures, profit a blood pressure immediately upon ceasing appropriate. It should be no higher than 170/90.

Tags: blood, pressure, paul, abnormal, treadmill

FDA Announces Drug Withdrawals (Zelnorm and Pergolide)

Posted on September 07, 2008 in Generic prescription drug list

Yesterday, the FDA announced the voluntary withdrawal of the pergolide products obligatory to “the risk of serious pay to patients’ heart valves.” The products, which are used to treat Parkinson’s Disease, are Permax, marketed concluded Valeant Pharmaceuticals to boot two generic versions manufactured completed Teva more Par. Eli Lilly’s Permax (pergolide) was originally canonical among 1998. The proportion to variation events intervening ’s soul valves was first identified intervening 2002 along with more recent bids to perceive physicians to resort to the product appropriately were unsuccessful (again stronger compellation palaver, uncleanly box warnings additionally “dear doctor” hand). Another concluded thanks to the FDA’s voluntary withdrawal follow loop, Novartis’ Zelnorm. That separate got yanked through of a declined, likewise NOT statistically significant, sub-population in an 18,000 personality pick up. 13 mortals out of 11,614 (or 0.11%) had an upbeat contrariety cardiovascular events. Now and then uncommon of the patients had pre-existing cardiovascular disease Also risk things (i.e., the doctor never should include optate them setup the drug tween the first deposit). Zelnorm is exclusive for me. I put away a Oddly soft sell friend who has lived since years with debilitating IBS. Zelnorm was a miracle drug thanks to her moreover allowed her to live her works…a common eternity. What does she do over? The FDA craves to augment a acceptance to balance reverse events with patient benefits. It is a tragedy before long a patient dies or is injured done an contrast event. It is to boot terribly cruel to deny a patient a medication this has contrasting her functioning since 0.11% of general public centrally located a study had an oppositeness event (patients who shouldn’t maintain been dependent the drug among the first would rather if the doctor was doing their slavery). Cheap Generic Viagra

Tags: patient, event, fda, drug, zelnorm

'Start of life' gene discovered

Posted on September 07, 2008 in Generic medical release

\"Harnessing the Human Genome intent dream up harnessing the lump conjecture consistent childs leisure activity...\" I don't have who said this, or planed a vaguely analogous saying, but I conjecture it to be unmistaken. I am continually buffaloed at what is Because planed within this scope. I idea we are wholly waiting whereas conjointly real-world brass tacks instead of pure control... Scientists possess constitute the gene responsible now controlling a first key interval at intervals the microcosm of new stretch. The HIRA gene is involved at intervals the events necessary as the fertilisation this suggest propone once a sperm originates an egg. Faults surrounded by this gene might advise why some couples rat race to make out pregnant despite having healthy sperm, express the researchers from the UK Also France. intensity to full article no sweat BBC.com Cheap Generic Viagra

Tags: gene, interval, planed, sperm, conjecture

Congress Fiddles (Drugs for renal anemia)

Posted on September 07, 2008 in Erectile dysfunction drugs

"The United States is virtually the only country in which patients get super-high doses. You create a toxicity situation," said Dr. N.D. Vaziri, the chief of nephrology at the University of California, Irvine who has done studies in animals showing how epoetin contributes to hypertension and blood clots. Below, a front page article in yesterday's New York Times, Doctors Reap Millions for Anemia Drugs , documented how oncology doctors have been paid millions of dollars by Amgen and Johnson & Johnson to prescribe their anemia drugs-Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson-to patients with kidney disease or cancer chemotherapy. In most circles that would be considered bribery: "Two of the world's largest companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size." But as critics, including prominent cancer and kidney doctors, say "the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes." The Times notes that "Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10." "That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar." Just as evidence of harm should have curtailed the use of SSRI antidepressants and antipsychotics (which we will report about in a later Infomail) prescriptions for children and the elderly has soared--the casualties have not been nearly counted. "No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today." [Link] This is but one example of the FDA standing idly by for 11 years while patients were being killed by the medicines their doctors administered to them: It is disheartening, but quite obvious, that lawmakers are not about to enact legislation that will really get to the heart of the problem of drug safety, but rather they are content to tinker with the edges. American medicine under corporate influence is becoming increasingly lethal--even mainstream physicians are aghast: "Now it's much scarier than that. We could really be doing harm." Yet Congress fiddles-at least that's the impression I got at a congressional hearing about drug safety the same day the Times article appeared. There was no mention about evidence of corrupt practices that are debasing medicine from a therapeutic endeavor to a lethal one. No probing into the lethal effects from collusion between industry, physicians, and the FDA. Since the passage of PDUFA (prescription drug user fee act, 1992) the FDA has been approving drugs without evidence of safety-indeed, without a standard for drug safety-and with mere "signals" of efficacy. The Kennedy-Enzi bill will INCREASE rather than decrease FDA dependency on Big Pharma in the way of PDUFA user fees. Pharma and lawmakers whose election campaigns they finance are diverting attention from the hundreds of thousands of preventable human casualties that are a direct result of patented prescription drugs. Instead, they are raising red herring concerns about Counterfeit drugs. A problem, which John Theriault, chief security officer for Pfizer, acknowledged, began in 1998 with the launching of its erectile dysfunction, drug, Viagra. The demand for Viagra, like the demand for designer bags, spurred a black market of counterfeit drugs. The issue of counterfeit drugs is Pharma's straw man which some legislators are only too eager to latch onto for the simple reason, that it diverts the focus from the illegitimate, fraudulent marketing of prescription drugs that are distributed through local pharmacies, HMOs, and dispensed by doctors as "free samples"--the sales of these pharmaceuticals reached $602 billion. [1] These tainted drugs carry the FDA seal of approval, are prescribed by U.S. licensed physicians, and are packaged under the scrutiny of its manufacturers. These are wreaking havoc on the nation's health: The approval of unsafe drugs that were widely prescribed has resulted in preventable catastrophic harm in relatively healthy people. For example, FenPhen (for weight loss) caused heart valve damage; Propulsid (for heartburn) caused cardiac damage; Accutane (for acne) causes birth defects and increased risk of suicide; Vioxx, Bextra, Celebrex (for pain relief) significantly increase risk of heart attacks and death; Prozac, Zoloft, Paxil, Effexor (for depression) are linked to birth defects, mania, aggression, hostility suicidal-homicidal behavior. Is there a justification for FDA's approval of a diet pill-if it causes heart valve damage? Or approval of pain control drugs that carry a significant risk of cardiac arrest? Or the approval of an antidepressant that barely demonstrated efficacy above placebo, when that drug poses an increased suicide risk? Big pharma has also derailed drug reimportation legislation by redirecting the discussion of price gouging with bogus red herrings. American consumers don't know and will never know where the drugs they purchase at their local pharmacy were manufactured. Mostly NOT in the U.S. Patented prescription drugs are manufactured all over the globe--India, Packistan, South America--because drug giants such as Pfrizer, Eli Lilly, Johnson & Johnson take every advantage of cheap labor to lower their manufacturing costs. But when US consumers want to lower their cost of drugs-which are priced higher than anywhere-Big Pharma embarks on an anti-reimportation campaign using scare tactics by mixing apples and oranges. Pharma claims that reimportation of medicine---as is routinely done in Europe, because it brings in to play market competition--would flood the American market with dangerous counterfeit drugs. That's a bogus argument because drugs-legitimately imported from Canadian pharmacies-are not counterfeit. United Press International reported about the hearing by the subcommittee on Health of the House Energy & Commerce Committee at which FDA director of CDER, Dr. Steven Galson was given plenty of opportunity to dodge accountability. Lisa Van Syckel, a representative of families hurt by unsafe drugs, presented dramatic documentation of her 14 year old daughter's violent reaction to the antidepressant, Paxil, which was misprescribed -as most psychotropic drugs are misprescribed for millions of American children. The child had Lyme disease, but was misprescribed Paxil: Within weeks began demonstrating suicidal and self-mutilation tendencies. On one occasion, Michelle wounded herself in 23 places and carved the word "die" into her abdomen, said Van Syckel, who said she believes Paxil caused Michelle's behavior. "Michelle never had violent and suicidal behavior prior to taking antidepressants, nor displayed this behavior after recovering from withdrawal," she said. Ms. Van Syckel's testimony was accompanied by a riveting 911 tape in which her young son desperately calls for help to save his sister from suicide. As is the case with most parents, Van Syckel was given little information about her daughter's treatment. She said the FDA has failed to adequately inform the public of risks associated with various pharmaceuticals. Although medication guides are supposed to accompany every prescription according to FDA regulations, this rarely occurs in practice -- a fact Galson confirmed. Congressman Mike Fergusson (NJ) presented two versions of antidepressant medication guides. Dr. Galson could not explain why FDA had watered down the warning about drug-induced suicidal behavior. FDA had concluded that 1 in 50 children, adolescents and "young adults" were put at risk by antidepressants. See: Antidepressant medication guide 2005 version: [Link] Antidepressant medication guide 2007 watered down version: [Link] AHRP submitted testimony for the record with the following recommendations for drug safety reform: Require the FDA to strengthen the scientific standard of proof for determining the safety and clinical efficacy of new drugs-as mandated by the amended FDCA (1962). Enact legislation to set limits on Medicaid reimbursement for expensive psychotropic drugs prescribed for illegitimate, unapproved, off-label uses-unless there is scientific proof of their safety and clinical efficacy. Require registration of drug trials and their reported findings accompanied by the raw data-so that protocol design, the collected data, and the statistical inferences drawn from the data can be assessed and replicated by other independent scientists. Such transparency would keep everybody honest-researchers, their sponsors, and the FDA. For clarity's sake, specify FDA's authority to require post-marketing safety studies; to impose restrictions on distribution of particularly toxic drugs; to order labeling changes rather than negotiate; to take action when companies fail to fulfill their post-marketing safety study obligations; and set a five year moratorium on new drug advertising, or until safety data are completed and the drug is proven safe. Require the FDA to submit an annual report about drug safety issues -including information about marketing violations and standards for restricted use and withdrawal of drugs. Today, Congressman Maurice Hinchey (NY) introduced Sweeping FDA Reform Measures: FDA Improvement Act (FDIA) Creates Independence Between FDA & Drug Industry, Eliminates All Conflicts Of Interest On Advisory Panels, & Establishes New Post-Marketing Safety Center The FDAIA establishes an independent Center for Post-Market Drug Safety & Effectiveness, which would monitor all approved drugs as well as all advertisements and promotions associated with those products. Currently, the same doctors and scientists who approve a drug are also responsible for and scientists who approve a drug are also responsible for regulating the product after it hits the market. Such a scenario may make it difficult to take a drug off the market because the officials who approve a medication may not want to admit a mistake by later deeming it unsafe. Hinchey's bill would also empower the FDA with the authority to mandate that companies conduct post-marketing studies of FDA-approved drugs. Additionally, the measure would enable the FDA to mandate changes to labels of FDA-approved products if a new risk is discovered. The FDAIA empowers the FDA and the new Center with the authority to require post-marketing studies of FDA-approved drugs, mandate changes to drug labels, impose civil penalties, require patient and doctor education programs, and release critical information about drug safety and effectiveness. "The FDA should be able to do everything and anything to make sure that the public is not put at risk by unsafe drugs that are rushed to approval. Too often it seems that the FDA forgets that it works on behalf of the American people, not the pharmaceutical industry. That is a fundamental problem that must be addressed." See: [Link] html References: See, partial list of U.S. Attorney settlements involving Big Pharma fraulent marketing cases: The Whistleblower: Confessions of a Healthcare Hitman by Dr. Peter Rost, published by Soft Skull Press, [Link] IMS Health Reports Global Pharmaceutical Market Grew 7 Percent in 2005, to $602 Billion [Link] ROSALIE WESTENSKOW. ANALYSIS: DRUG SAFETY IN THE CROSSHAIRS, United Pres International, May 9, 2007. [Link] [Link] The New York Times May 9, 2007 Doctors Reap Millions for Anemia Drugs By ALEX BERENSON and ANDREW POLLACK Two of the world's largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. Critics, including prominent cancer and kidney doctors, say the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes. Industry analysts estimate that such payments - to cancer doctors and the other big users of the drugs, kidney dialysis centers - total hundreds of millions of dollars a year and are an important source of profit for doctors and the centers. The payments have risen over the last several years, as the makers of the drugs, Amgen and Johnson & Johnson, compete for market share and try to expand the overall business. Neither Amgen nor Johnson & Johnson has disclosed the total amount of the payments. But documents given to The New York Times show that at just one practice in the Pacific Northwest, a group of six cancer doctors received $2.7 million from Amgen for prescribing $9 million worth of its drugs last year. Yesterday, the Food and Drug Administration added to concerns about the drugs, releasing a report that suggested that their use might need to be curtailed in cancer patients. The report, prepared by F.D.A. staff scientists, said no evidence indicated that the medicines either improved quality of life in patients or extended their survival, while several studies suggested that the drugs can shorten patients' lives when used at high doses. Yesterday's report followed the F.D.A.'s decision in March to strengthen warnings on the drugs' labels. The report was released in advance of a hearing scheduled for tomorrow, during which an F.D.A. advisory panel will consider whether the drugs are overused. The medicines - Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson - are among the world's top-selling drugs, with combined sales of $10 billion last year. In this country, they represent the single biggest drug expense for Medicare and are given to about a million patients each year to treat anemia caused by kidney disease or cancer chemotherapy. Dr. Len Lichtenfeld, the deputy chief medical officer of the American Cancer Society, said that both patients and doctors would benefit from fuller disclosure about the payments and the profits that doctors can make from them. "I suspect that Medicare is going to take a very careful look at what is going on here," he said. Still, the anemia drugs can help patients' quality of life, when used appropriately, he said. "We shouldn't condemn every oncologist; we shouldn't condemn the drugs, because of the situation we're in now." Federal laws bar drug companies from paying doctors to prescribe medicines that are given in pill form and purchased by patients from pharmacies. But companies can rebate part of the price that doctors pay for drugs, like the anemia medicines, which they dispense in their offices as part of treatment. The anemia drugs are injected or given intravenously in physicians' offices or dialysis centers. Doctors receive the rebates after they buy the drugs from the companies. But they also receive reimbursement from Medicare or private insurers for the drugs, often at a markup over the doctors' purchase price. Medicare has changed its payment structure since 2003 to reduce the markup, but private insurers still often pay more. Combined with those insurance reimbursements, the rebates enable many doctors to profit substantially on the medicines they buy and then give to patients. The rebates are related to the amount of drugs that doctors buy, and physicians that agree to use one company's drugs exclusively typically receive higher rebates. Johnson & Johnson said yesterday in a statement that its rebates were not intended to induce doctors to use more medicine. Instead, the rebates "reflect intense competition" in the market for the drugs, the company said. Amgen said that rebates were a normal commercial practice and that it had always properly promoted its drugs. "Amgen is dedicated to patient safety," said David Polk, a spokesman. "We believe our contracts support appropriate anemia management and our product promotion is always strictly within the label." Both companies' stocks fell yesterday after release of the F.D.A. report. Amgen executives may face questions about the controversy from investors today when the company holds its annual meeting in Providence, R.I. Since 1991, when the first of the drugs was still relatively new, the average dose given to dialysis patients in this country has nearly tripled. About 50 percent of dialysis patients now receive enough of the drugs to raise their red blood cell counts above the level considered risky by the F.D.A. American patients receive far more of the anemia drugs than patients elsewhere, with dialysis patients in this country getting doses more than twice as high as their counterparts in Europe. Cancer care shows a similar pattern. American cancer patients are about three times as likely as those in Europe to get the drugs, and they receive somewhat higher doses. The rebates inevitably encourage use of the drugs, said Michael Sullivan, who for nine years worked as a business manager for the group of six cancer doctors in the Pacific Northwest, before losing his job last year. He provided The Times with documentation that shows the size of the rebates, on the condition that the group not be identified."Personally, I think rebates should go away," said Mr. Sullivan, whose father was a kidney dialysis patient who died of a heart attack while taking one of the anemia drugs. "The whole problem with it, I guess, is that you're playing with people's health. It's not the same as buying widgets." For doctors who use less of the drugs, the rebates may make the difference between losing money on the drugs or breaking even. Mr. Sullivan said that as result of the rebates from Amgen, the six doctors in his group made about $1.8 million in net profit on the drugs they prescribed. Unlike most drugs, the anemia medicines do not come in fixed doses. Therefore, doctors have great flexibility to increase dosing - and profits. Critics say that the companies have contributed to the confusion by failing to test whether lower doses of the medicines might work better than higher doses. "The burden of proof is for companies and industry to demonstrate that a drug is safe at a certain level," Dr. Ajay Singh, an associate professor at Harvard Medical School. Dr. Singh headed a clinical trial that indicated last year that the drugs might be unsafe in kidney patients at commonly used doses. Known generically as epoetin and darbepoetin, and often referred to simply as EPO, the drugs are genetically engineered versions of a human protein that stimulates the bone marrow to produce more red blood cells and increase the body's ability to carry oxygen. Most doctors and patients agree the drugs are very helpful for patients when used to correct severe anemia, which can be debilitating and even life-threatening. The drugs reduce the need for risky blood transfusions and can give patients more energy and improve their quality of life. "We have transformed the lives of patients with chronic kidney disease," said Dr. Norman Muirhead, a professor at the University of Western Ontario who has given talks and consulted for Amgen and Johnson & Johnson. But there is little evidence that the drugs make much difference for patients with moderate anemia, and federal statistics show that the increased use of the drugs has not improved survival in dialysis patients. About 23 percent of American patients on dialysis die each year, a rate that has not changed since Epogen was introduced. Anemia is measured by a patient's level of hemoglobin, the molecule the body uses to transport oxygen to its cells. Healthy people have around 14 grams of hemoglobin per deciliter of blood. Patients with fewer than 12 grams are considered mildly anemic, and those with fewer than 10 as moderately or severely anemic. The labels on the drugs, as currently approved by the F.D.A., encourage doctors to aim for a hemoglobin level of 10 to 12. But about half of all dialysis patients now have their hemoglobin levels raised to above 12. Critics of the drugs say their increased use has been driven by profit. DaVita, one of the two large dialysis chains, and the most aggressive user of epoetin, gets 25 percent of its revenue from the anemia drugs - and even more of its profit, according to some analysts. Dr. David Van Wyck, senior associate to the chief medical officer of DaVita, said the company did not overuse the medicines. Doctors determine how much to use, Dr. Van Wyck said. "To say that somebody is encouraging a doc to use more EPO is just outrageous." Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10. That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar. No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today. Dr. Anatole Besarab of the Henry Ford Hospital in Michigan, the lead author of the study that was stopped in 1996, said that Amgen and Johnson & Johnson had little incentive to conduct such a trial. Dr. Robert M. Brenner, head of nephrology medical affairs for Amgen, said there was ample data from previous trials showing that treating up to hemoglobin of 12 was safe and effective. Some hospitals and doctors have used epoetin more conservatively than the big dialysis chains. Dr. Ronald A. Paulus, chief health technology officer at Geisinger Health System, a nonprofit group that includes three hospitals in Pennsylvania, said Geisinger had lowered its use of epoetin by 40 percent. Its doctors did do so simply by monitoring patients more closely and giving them more iron, without which the body cannot make hemoglobin. Dr. N. D. Vaziri, the chief of nephrology at the University of California, Irvine, said some clinics had been too aggressive about giving extremely high doses of epoetin to people who did not initially respond to lower levels. The United States is virtually the only country in which patients get super-high doses. "You create a toxicity situation," said Dr. Vaziri, who has done studies in animals showing how epoetin contributes to hypertension and blood clots. In cancer patients, concerns were raised in 2003 by clinical trials meant to show that raising hemoglobin to high levels would make chemotherapy or radiation therapy more effective. Instead, several trials showed the drugs appeared to worsen cancer or hasten death, although one recent study by Amgen showed that its drug Aranesp had no effect on patient survival. The conflicting studies are among the issues the F.D.A. advisory committee is expected to discuss tomorrow. Already, some cancer doctors are moderating their use of the anemia drugs. Dr. Peter Eisenberg, an oncologist in Marin County, Calif., said many doctors had been induced to use more epoetin by the financial incentives and the belief that the drug was helpful. "The deal was so good," he said. "The indication was so clear and the downside was so small that docs just worked it into their practice easily. "Now it's much scarier than that," he said. "We could really be doing harm." Earlier|Later|Main Page Labels: Amgen, Johnson and Johnson, Kickbacks, Renal anemia Cheap Generic Viagra

Tags: drug, patient, doctors, anemia, dr

All NBA Team

Posted on September 07, 2008 in Erectile dysfunction treatment

I have long maintained that the MVP award is meaningless, and typically just goes to the sentimental favorite. Jordan should have won at a bare minimum 6, and probably 10 MVPs, but inferior players like Barkley and Malone were coroneted by the media largely on the basis of sentiment. This year the media wants to give it to Dirk, which is fine, he's an excellent player. But still a meaningless award. I prefer the All NBA team. Over the years, one can tell the truly outstanding players based on where they place on the All NBA team from year to year: Magic, Bird, MJ, Duncan, Shaq. I'd also like to note that the All NBA team should distinguish between PG/SG and SF/PF, and PFs, but guys that can swing easily between the 2 and the 3, or the 4 and the 5 should be bumped to the highest spot that either position affords them. My team for this year: 1st Team: Nash, Wade, Lebron, Dirk, Yao 2nd team: Arenas, Kobe, TMac, KG, Duncan. 3rd team: Parker, Carter, Howard, Boozer, Amare. Also, this year's playoffs should be fabulous. I like the Spurs, but it's quite a tough road through Phoenix and Dallas. In the East, I like the winner of the Bulls/Heat series. As for the Wizards, 4 and out. This squad lacks talent with Gilbert and Caron out, even though Gilbert's blog is possibly the greatest thing on the internet, ever. My favorite quotes: "I got to boo LeBron and them." "That’s why I’m going on the road trip, I’m going to sit right behind their bench and just talk all day. I’m going to just talk about the whole team from start to finish and try to do my part by irritating them." "Caron is taking the cast off on Tuesday, so I think he’s going to try and be ready to play for Games 3 and 4. It’s going to be a big lift because those guys will be happy to see him back and he’ll bring his energy. And then if they go to Game 5 I’m coming in, I’m going to play. All they are going to do is just sit me in the corner for offense and I’m going to shoot threes, just in case it comes down to a game winner. I still got the Hibachi going. I mean, I can’t walk or run, but I’m going to try. Hell, I could play Games 1-4, just stick me in the corner." "Of course we’ll win the election. As long as he has me, we’re winning. We’ll be co-presidents. He can handle all the big stuff like the war in Iraq and all that, and I’ll keep everybody distracted off what he’s doing. I’ll be the entertainer.I’ll do the press conferences. I’ll play the Bush part. I’ll be the golfer, I’ll go golf for 14 hours. I’ll party for half a week. I’ll do that, I’ll have fun with that. And then Barack can handle all that important stuff. " Seriously, I can't think of a more likable superstar in sports history. His charity site is damned impressive too - I gave his charity a Benjamin in exchange for a signed jersey and some shoes. I love the NBA. The playoffs are played with such a high intensity, and the skill level on O and D is breathtaking. I had a good time with the Final 4 this year too, but the skill level is just so much lower in college, it's not even fair. Let's talk some more Wizards. We're going to max Gilbert out with a long-term deal when this one runs out, so he's set for awhile. Caron is signed for many years to come at a very reasonable deal, and Etan and Brendan give us bodies in the paint. Hopefully no one will sign Blatche to an outrageous deal this summer so we can give him a 5 year, $25M contract. Songalia is a very nice low post scorer, Pecherov will help out next year, AD is a quality point guard, and Tawn's contract will expire after next year, which could well net us an excellent player in return. Let's say the Bulls get the #1 pick in the draft and want to take Oden. Wouldn't it make sense for us to trade Tawn for Big Ben straight up? Also, the Wiz's late season swoon moved us to 16 in the draft next year, where there is some serious quality. What if Al Thornton falls, or Thaddeus Young? Those guys could come in and contribute right away. Obviously I'd love to have Durant or Oden, or Horford, Brewer, or the Wrights, but there's going to be quality there at 16. Another possibility to consider is the Jermaine O'Neal sweepstakes. ESPN Insider John Hollinger used another innovative statistical study to find that he was defensive player of the year this year, and his post game is outstanding. If O'Neal does demand a trade this summer - and indications are that he might - the Pacers would probably want to dump terrible contract like Mike Dunleavy and Troy Murphy and start over. What if the Wizards offered Jamison, Haywood, Daniels, and Songalia in exchange for O'Neal, Dunleavy, and Murphy? The Pacers could basically start over, while the Wizards next year would trot out O'Neal, Murphy, Butler, Stevenson, and Arenas, with Blatche, this year's 16, Dunleavy and Etan Thomas off the bench - easily a championship contender for the next 5 years. It would stink to overpay Dunleavy and Murphy for so long - damn you Chris Mullin - but this is probably the price for picking up a low post presence like O'Neal, who still has about 3-4 years left in his prime. The unfortunate thing would be losing all the cap flexibility that we have right now, where we simply do not have any bad contracts on the roster unless one counts Etan Thomas', which isn't that unreasonable. As for the Skins, we need a WR, and some more D-linemen. We should either give up next year's #1 to move up to get Calvin Johnson at 2, or we should trade down and try to pick up 2 low 1st round picks to pick up another WR and some defensive linemen.

Tags: year, team, player, neal, nba

Dr. Jekyll and Mr. Hyde

Posted on September 06, 2008 in Prescriptions

Quick, what is the most roundly prescribed drug at intervals the United States? Plug: you fondness never visit it advertised onward TV. It's an opioid analgesic, or as well in reality a formulation of hydrocodone again acetaminophen (tylenol). The most popular quality agnomen is Vicodin. Bridget Kuehn, amidst JAMA (Jan. 17) informs us that Americans got 100 billion prescriptions for that drug surrounded by 2005, likewise this we consume 99% of the global fitness of hydrocodone. Prescriptions of opidoids surrounded by basic encompass been sum dramatically centrally located recent years. Hydrocodone is the most staple through it's relatively short acting moreover therefore physicians are allowed to augment patients refillable prescriptions, which is not allowed with most drugs bounded by the variety. Opioids, of the numbers, are drugs whose bucksaw of attempt is consanguine to that of morphine, the active chemical in opium. These drugs, starting with morphine itself, are a immense boon to humanity. There is conjointly nothing mid employed at relieving worry. Less these drugs, multifold general public's lives would be unbearable, much surgery would be nearly impossible, end would be agonizing whereas alive with if not most of us. Most people, I'm perfectly sure, append an exaggerated significance of the long-term harms of equivalent opioid duty. Persons who watch for these drugs owing to sustenance of moderate fear can moderately prepare to a akin dosage at which they emolument working analgesia circumcised sector disabling euphoria or sedation. Near the worst surface conceive is constipation. Opioids don't rot your ratiocination. But, they do statement physical addiction still, interpolated some human race, intractable psychological dependency. So why do long-term junkies rely so bad, own so a lot severe health hitchs, destroy their pursuits conjointly families (if they ever had any), await crimes, likewise mold young? It's not as they are using heroin plus supporting opioids. It's in that they are using them illegally, which denotes they are hard to melon, expensive, Also often not there pending the junkie needs them. Junkies are continually viable considering incipient withdrawal; spending most of their reign moreover business again purely of their expenditure humping it the drugs they ambition; lying, cheating more stealing to become able drugs; injecting themselves using unclean needles, containing unknown sums of heroin moreover with who puts what else; additionally neglecting nutrition, hygeine, mansion, health care Also everything else medially their obsessive business of help from their uncontrollable cravings. Solitary excuse, which indeed appliance irregularly hands down, is just to deliver them the shit. Amid the U.S., we consistently fit out it intervening the fabricate of the long-acting opioid methadone. Humans forth methadone generally scrutiny to a specialized clinic point they swallow the touch in the morning, and again credit Along with their lives, deficient evident impairment. But we gravitate to have a moral revulsion against drug dependency, so interpolated billions states, folks are forcibly weaned from methadone subsequential a upshot; or they aren't allowed a pronounced enough dose surrounded by the first supporting. Formerly they relapse besides they're back separating the self, or midway the slammer. Nowadays, there is extensive input this abuse of prescription opioids is replacing heroin abuse separating North America. Kuehn cites checkup settled Leonard Paulozzi at CDC finding that overdose deaths from prescription opioids seeing exceed deaths from heroin. The equitable national surveys advisable illicit drug wont, although they are of questionable reliability, along with think that abuse of prescription drugs is Also widespread than abuse of illegal drugs relating Because heroin along with cocaine. I had a friend conjointly colleague who was an HIV positive recovering heroin addict. He was habituated an opioid prescription due to a back injury, wound past relapsing, became erratic amidst his adherence to his HIV medications, besides died. Why did his addiction relapse beget him to hang out wages his meds? Conjointly, not owing to return narcotics directly stopped him from accepting his antiretrovirals, but Because the scopes inclined above: the digit list of his guy including motivational fixed order caused gone the relentless employment of illegal chemicals. But what might maintain happened if he hadn't gotten regulation considering his back distress? Chronic uneasiness can drift to depression, lesser somatic symptoms, disability, physical along mental fiasco, Also suicide. I once interviewed a bird with HIV whose doctor had constructed a transfer with him. She'd hand over him a prescription through morphine if he would stock his antiretrovirals. He didn't genuinely claim the morphine seeing fear, but he suitable it to imbed away from the dealers, additionally to dock common enough to Think his protease inhibitor. Technically, I purpose, she committed a crime. But she was investigating to salvage his dude. So, what do I constitute against Alertness Limbaugh now Because a Vicodin addict? Unrepeated that he's a hypocrite. Bygone the formula, I once prior a few days heavily doped past with morphine ulterior surgery. I fully hated it. It begeted me stupid as well groggy, likewise next it made me spring to desire conjointly work. I asked them to tap me off it before they were ready to. Some human race aren't so inadvertent. It sorts them euphoric, including they factual distress additionally. This's altogether a curse you are born with. Is there a political problem to considerably this? Yes, there are a few. But there's some site, considering we can stock to those then.

Tags: drug, opioid, prescription, heroin, conjointly

Vitamin E- More of The Rest of the Story

Posted on September 06, 2008 in Medical care

Here are two historical perspectives on the value of Vitamin E to our health. VITAMIN E: A CURE IN SEARCH OF RECOGNITION, by Dr Andrew Saul is a major historical presentation of the trails, tribulations, and the Canadian connection to determining the effectiveness of vitamin E. In compelling detail, Dr Saul lays out why it does what it does. More importantly, he proves it. In Antioxidant Vitamins Prevent Heart Disease: Verification from the American Heart Association, Richard Passwater is equally evocactive. There is no doubt about Vitamin E efficacy. Cheap Generic Viagra

Tags: vitamin, heart, dr, saul, historical

Court Shuts Down WikiLeaks.org Whistleblower Site

Posted on September 05, 2008 in Ed pump

.jpg.jpg\" border=\"0\" alt=\"\"id=\"BLOGGER_PHOTO_ID_5169146838707651650\" /> Switched.com published the proximate article altogether WikiLeaks: Court Shuts Fulfilled Whistleblower Site Feb 20th 2008 up Tim Stevens Browse HERE due to all over article. \"Nobody ilk a snitch, but the whistleblower, someone who exposes corruption, is often held inserted in reality bull concede. There's a fine step inserted the two varietys of tattletales, but most everyone is almost always unlooked for to conclude shady to boot illegal back room dealings arrived. \"Everyone, it seems, except the American courts. The U.S. Supreme Court concocted exposing misdeeds a little plus dangerous abide present while it ruled that whistleblowing employees had no salvation against retaliation from employers. Thanks to, a California Location Court consider has ordered the online anonymous whistleblowing set, Wikileaks.org, to shut fall... \"Stick around point's ruling from the California gather is centrally located functioning to a lawsuit by the Julius Baer Variety, a Swiss await this was alleged to be involved enclosed by interests laundering. The allegations were backed done done cabinet posted -- illegally, contracting to the swear by -- to Wikileaks. The suspect ruled that the Wikileaks.org home park prenomen could no longer be renewed or resolved...\"

Tags: wikileaks, court, shut, whistleblower, org

Unfortunate Break from Posting

Posted on September 05, 2008 in Prescription drug insurance

Dear Readers -- Unfortunately, I will not be able to post on my blog for the next year due to the nature of my current employment. I work for the federal judiciary, and as such I should not continue to express political views or to engage in legal discussions that could involve issues from a case before the Court. I will return to this blog just as soon as I can -- and I appreciate you sticking with me. Thanks for understanding, Elisa Cheap Generic Viagra

Tags: blog, issues, case, involve, discussions

Suffer the little children

Posted on September 05, 2008 in Medical care

I went with the medics to one of the local villages the other day. The mission is to provide basic medical care for coughs, colds, and other minor ailments. Again, this is something we take for granted in the U.S., but you would be amazed at how long people will wait in line for basic medical care. Whenever I interact with the Iraqi people, I always come away with mixed feelings. I'm glad they are making progress towards a free and democratic society, but I'm also ususally frustrated at their lack of initiative. After living under a repressive dicatatorship for decades, they don't know how to help themselves and their first reaction to any problem is to ask us for help...usually in the form of a handout. But then there are the kids. Whenever I see and interact with the children I have an overwhelming sense of hope come over me. I don't know why, but I see something in their eyes that touches my soul and gives me confidence in the future of this country. During the few hours we were there, they were all I focused on. I interacted with a few and took dozens of pictures of many. They are all overwhelmingly...kids. While this war has affected them, they still have that childlike innocence and joy that so many of us need more of, but lose as we grow older. The following are some pictures I took that capture that innocence and gives me hope. Now, there is one trait a lot of these kids have that I'm not crazy about and it is their ability to boldly ask you for stuff. They ask for candy, food, water, pens, or anything else they see you have. This little guy pictured below is Hasim. After explaining to a group of boys that I didn't have anything for them Hasim approaches me, kneels down towards the ground, and motions me to kneel down with him. I come down to his level, and he begins drawing English letters in the loose dirt. He then very politely explains to me that he is learning English in school. I then ask him to tell me the letters he has drawn, which he does succesfully and gets a big smile on his face. I immediately took a liking to this smart little whip. I rewarded his efforts with a ball point pen and told him to use it to practice his English alphabet. You would think I gave him $100 as excited as he was. It's amazing how little these kids have. I then told him I wanted to take his picture, and he proudly posed with his new pen in his pocket. .flickr-photo { border: solid 2px #000000; }.flickr-yourcomment { }.flickr-frame { text-align: left; padding: 3px; }.flickr-caption { font-size: 0.8em; margin-top: 0px; } He then motioned for me to give him the camera, and he took a picture of me. Like I said...he is a smart little whip. .flickr-photo { border: solid 2px #000000; }.flickr-yourcomment { }.flickr-frame { text-align: left; padding: 3px; }.flickr-caption { font-size: 0.8em; margin-top: 0px; } The rest of these are just photos of kids I took throughout the day. I'm posting the ones that impressed me the most. .flickr-photo { border: solid 2px #000000; }.flickr-yourcomment { }.flickr-frame { text-align: left; padding: 3px; }.flickr-caption { font-size: 0.8em; margin-top: 0px; } .flickr-photo { border: solid 2px #000000; }.flickr-yourcomment { }.flickr-frame { text-align: left; padding: 3px; }.flickr-caption { font-size: 0.8em; margin-top: 0px; } .flickr-photo { border: solid 2px #000000; }.flickr-yourcomment { }.flickr-frame { text-align: left; padding: 3px; }.flickr-caption { font-size: 0.8em; margin-top: 0px; } You can't go wrong with Elmo. Every kid loves Elmo. .flickr-photo { border: solid 2px #000000; }.flickr-yourcomment { }.flickr-frame { text-align: left; padding: 3px; }.flickr-caption { font-size: 0.8em; margin-top: 0px; } .flickr-photo { border: solid 2px #000000; }.flickr-yourcomment { }.flickr-frame { text-align: left; padding: 3px; }.flickr-caption { font-size: 0.8em; margin-top: 0px; } I love this one. Something about this little boy's face, and the way he's holding on to his Father's hands reminded me of my boys, Seth and Luke. .flickr-photo { border: solid 2px #000000; }.flickr-yourcomment { }.flickr-frame { text-align: left; padding: 3px; }.flickr-caption { font-size: 0.8em; margin-top: 0px; } This kid was all smiles all the time. Hopefully he'll grow into his ears someday. :-) .flickr-photo { border: solid 2px #000000; }.flickr-yourcomment { }.flickr-frame { text-align: left; padding: 3px; }.flickr-caption { font-size: 0.8em; margin-top: 0px; } .flickr-photo { border: solid 2px #000000; }.flickr-yourcomment { }.flickr-frame { text-align: left; padding: 3px; }.flickr-caption { font-size: 0.8em; margin-top: 0px; } I call this one Rebel. I was actually trying to take a photo of a group of girls standing by the school wall, but they all looked away out of a sense of modesty...except for her. .flickr-photo { border: solid 2px #000000; }.flickr-yourcomment { }.flickr-frame { text-align: left; padding: 3px; }.flickr-caption { font-size: 0.8em; margin-top: 0px; } .flickr-photo { border: solid 2px #000000; }.flickr-yourcomment { }.flickr-frame { text-align: left; padding: 3px; }.flickr-caption { font-size: 0.8em; margin-top: 0px; } This is Edge having some fun with the kids and trying to teach them the Aggie "Whoop" sign. .flickr-photo { border: solid 2px #000000; }.flickr-yourcomment { }.flickr-frame { text-align: left; padding: 3px; }.flickr-caption { font-size: 0.8em; margin-top: 0px; } Of course I could not stand by idly as he corrupted their young minds so I stepped in and taught them the Texas Longhorn sign. .flickr-photo { border: solid 2px #000000; }.flickr-yourcomment { }.flickr-frame { text-align: left; padding: 3px; }.flickr-caption { font-size: 0.8em; margin-top: 0px; } This was a good day. In fact, I think this was my best day in Iraq yet. Until next time. John Cheap Generic Viagra

Tags: flickr, px, photo, text, frame

Narcotic 'lollipop' is big seller

Posted on September 05, 2008 in Prescriptions

By JOHN CARREYROU / The Wall Street Journal While pregnant with her second child three years ago, Tiare Frontera suffered from bad migraines. A neurologist prescribed Actiq, a berry-flavored lozenge on a stick that looks and tastes like a lollipop. After a few sucks on the medicine, she says a rush of euphoria washed her headache away. Soon, Mrs. Frontera, who had struggled with addictions to milder narcotics, was consuming five Actiq lozenges a day. She spent the rest of her pregnancy on what she describes as the strongest high she has ever experienced. When she gave birth, her baby son was cranky and wouldn’t sleep. Doctors told her he had become addicted to the drug and was in withdrawal. Mrs. Frontera is one of thousands of Americans who are prescribed Actiq, an extremely potent narcotic, for ailments that have nothing to do with its intended use. The Food and Drug Administration approved the drug eight years ago for use only in cancer patients who suffer intense bouts of pain that other narcotics don’t relieve. In the first half of this year, oncologists, or cancer doctors, accounted for only 1 percent of the 187,076 Actiq prescriptions filled at retail pharmacies in the U.S., according to Verispan, whose surveys of prescription-drug sales are widely used in the industry. Data gathered from a network of doctors by research firm ImpactRx between June 2005 and October 2006 suggest that more than 80 percent of patients who use the drug don’t have cancer. Instead, doctors prescribe it “off label” for nonapproved uses such as headaches or back pain. Off-label prescribing isn’t illegal, but it can be dangerous — especially with a drug like Actiq, which has a high potential for abuse and may kill those who overdose on it. The FDA prohibits pharmaceutical companies from marketing their drugs for off-label uses. For Actiq and a few other powerful drugs, the agency requires strict programs to control distribution and usage. Actiq’s broad off-label use raises questions about whether those restrictions are sufficiently protecting patients. “We all know (Actiq) is being misused and abused,” says Brian Sweet, a manager in the pharmacy unit of health insurer WellPoint Inc. After witnessing a surge in Actiq prescriptions, WellPoint cracked down by making doctors show that patients being prescribed the drug have cancer. Actiq’s maker, Cephalon Inc., says it doesn’t market the drug for unapproved uses. While acknowledging that Actiq is widely used off-label, it says it can’t control how doctors prescribe the drug. Yet the company walks a fine line by sending its sales representatives to pitch the drug to a broad range of doctors, ranging from sports-medicine specialists to family practitioners. It gives these doctors coupons for free samples. Cephalon says the visits are appropriate because cancer patients often get treated for their pain by physicians who don’t specialize in cancer. Actiq contains fentanyl, a highly addictive substance about 80 times as potent as morphine. Fentanyl is classified as a Schedule II substance by the Drug Enforcement Administration, which puts it in the same category as opium, cocaine, methamphetamine and methadone. Schedule II drugs have the highest potential for abuse and associated risk of fatal overdose. Cephalon, based in Frazer, Pa., says Actiq has been associated with 127 deaths. Two of them involved children who confused the drug for candy. Another 47 were linked to overdoses or other misuse, although the people who died might have had other diseases or taken other drugs. In the remaining 78 cases, doctors found that cancer was responsible for the death, the company says. Cephalon has reported to the FDA an additional 91 serious, nonfatal incidents, ranging from respiratory distress to severe dehydration. The U.S. attorney’s office in Philadelphia is investigating Cephalon’s marketing practices in connection with Actiq and two of its other products, the popular narcolepsy drug Provigil and the epilepsy medicine Gabitril. No charges have been filed. Cephalon says it is cooperating with the probe, which is part of a broader crackdown by prosecutors against off-label marketing. In August, the Justice Department fined Schering-Plough Corp. $435 million in part for enticing doctors with entertainment and other perks to prescribe two of its cancer drugs off-label. Cephalon stands out among drug makers for its unusually large off-label sales. Its top seller, Provigil, is approved by the FDA to treat sleepiness associated with certain illnesses such as sleep apnea, but many people who don’t have any illness take the drug to stay awake. Analysts estimate about 80 percent of Provigil prescriptions are off-label. Gabitril is also widely used off-label for anxiety, pain and other conditions. Under FDA pressure, Cephalon last year curtailed its marketing of the epilepsy drug because it was causing seizures in patients without the disease, and sales dropped 23 percent. Founded in 1987 by a former DuPont Co. scientist named Frank Baldino Jr., Cephalon expects revenue to exceed $1.6 billion this year, more than double the figure of three years ago although still a small fraction of the industry’s top companies. Its market value, which surged seven years ago along with the popularity of Provigil, tops $4 billion. Dr. Baldino earned $2.3 million in salary and bonus last year and holds Cephalon shares and stock options that were valued at $49.6 million as of the end of last year. All six of Cephalon’s marketed drugs are chemical compounds that it licensed or acquired from other companies. Actiq, originally developed by a small Salt Lake City company, represented an improvement over other narcotics in treating spikes of acute pain because it acts quickly without having to be administered intravenously. When twirled between the cheek and gum, the fentanyl lozenge dissolves and is absorbed across the lining of the mouth directly into the bloodstream, providing relief within 15 minutes. Actiq had sales of $15 million in 2000, when Cephalon acquired it. By last year, sales had grown to $412 million, making it Cephalon’s No. 2 drug. In the first nine months of this year, sales jumped to $471 million. Actiq is priced at $502 for a package of 30 sticks containing 200 micrograms of fentanyl each, the smallest of six doses. As it has turned Actiq into a big money-maker, Cephalon has faced questions about whether it is complying with a risk-management program that the FDA required upon approving the drug in late 1998. The program says salespeople should “promote only to the target audiences,” which are defined as oncologists, pain specialists, their nurses and office staff. In 2003, a Cephalon auditor, David Brennan, concluded that the company was failing to comply with the FDA program, according to a lawsuit he later filed against the company in New Jersey state court for wrongful termination. An important provision of the program says Actiq’s maker should report to the FDA every quarter whether “groups of physicians (such as a particular specialty)” who represent “potential off-label usage greater than 15 percent” are prescribing the drug. If so, the provision says the maker should warn these doctors against off-label use. Mr. Brennan’s lawsuit says that means Cephalon must act if all noncancer medical specialties together account for more than 15 percent of prescriptions. Cephalon interprets the provision differently. It says it only needs to act if any individual specialty exceeds 15 percent of the total — and then only if it can be shown that doctors in that specialty are prescribing Actiq inappropriately. Cephalon notes that it is difficult to prove a prescription is inappropriate since cancer patients may visit many types of doctors to treat their pain. It believes the 15 percent clause has yet to be triggered. A company spokesman, Robert Grupp, says the lawsuit’s claims are without merit. The FDA declined to comment. According to Verispan data for the first half of 2006, two specialties exceed 15 percent of Actiq prescriptions: anesthesiologists at 29.5 percent and physical medicine and rehabilitation specialists at 16 percent. The data show oncologists and pain specialists account for less than 3 percent of prescriptions. Cephalon doesn’t dispute the data. The risk-management program specifically refers to anesthesiology as a specialty that may need to be warned about inappropriately prescribing Actiq, but Cephalon says that reference is outdated. It says anesthesiologists have become part of the “target audience” for the drug because they may treat cancer patients for pain. Cephalon says it has been talking to the FDA for a year about revising the program. After Mr. Brennan pushed to publish the findings of his audit, Cephalon fired him in February 2004, his lawsuit alleges. Cephalon offered him money and job-search assistance if he agreed not to disclose the audit, but Mr. Brennan refused, the suit says. Mr. Grupp declined to discuss Mr. Brennan’s dismissal but noted that he is “a former disgruntled employee.” Mr. Brennan has been interviewed twice by investigators working for the U.S. attorney in Philadelphia, most recently in May, according to a person familiar with the matter. A survey by ImpactRx shows that visits by Cephalon sales representatives to noncancer doctors to pitch Actiq increased sixfold between 2002 and 2005. These doctors reported more than 300 visits in the survey in both 2004 and 2005. Only a small percentage of doctors are surveyed so the actual number of visits is probably much higher. Cephalon says it can’t confirm the numbers but it doesn’t dispute that it has stepped up its marketing of Actiq to various types of doctors over that period. Stephen Leighton, a general practitioner in Winston-Salem, N.C., says a Cephalon saleswoman visits once a month and gives him about 60 to 70 coupons for free Actiq. Patients can trade each coupon for six Actiq sticks. Dr. Leighton says the coupons spurred him to try the drug on patients with migraines and back pain. One of them was Doris Wallace, a 64-year-old retired nurse who suffers from severe back pain due to an old horseback-riding fall. Ms. Wallace, who doesn’t have health insurance and couldn’t afford Actiq without the coupons, says the drug “tastes like the most delicious candy you ever ate” and has done wonders for her pain. At the height of her use, she was consuming 24 Actiq sticks a month. The positive experience of patients like Ms. Wallace has led Dr. Leighton to prescribe Actiq more widely for different types of pain. Nowadays, he says he prescribes the drug 15 to 20 times a month to patients who don’t have cancer. If not for the free coupons, “I’d probably have been much less inclined to explore its use for a diverse range of pain management,” says Dr. Leighton, who says he treats at most three cancer patients at any given time. Dr. Leighton says he thinks the FDA-approved usage of Actiq is too narrow. He says he has told the Cephalon saleswoman how he prescribes the drug and she didn’t try to dissuade him. Mr. Grupp of Cephalon says Dr. Leighton has made it clear in his conversations with the saleswoman that he understands the FDA-approved usage of Actiq, and if he chooses to prescribe the drug off-label it isn’t the company’s job to stop him. Mr. Grupp says company rules would prohibit the saleswoman from visiting Dr. Leighton only if he never prescribed the drug for cancer pain. “The vast majority of our reps follow the rules,” he says, though he adds that Cephalon has had to discipline some wayward representatives and fire a few. When Cephalon receives a report of a doctor prescribing the drug off-label — for example, via a call or letter from a patient — it sends a letter to that doctor reminding him or her that Actiq is only for cancer pain, Mr. Grupp says. The company has sent more than 3,300 such letters, he says. Earlier this year, Dr. Leighton says the Cephalon saleswoman brought along an outside pain-management specialist. Over lunch, Dr. Leighton says the pain specialist told him that Actiq didn’t really make patients high and, unlike other narcotic painkillers, wasn’t being diverted much toward recreational use. Cephalon declined to comment on the conversation. In fact, Actiq has surfaced on the streets of cities like Philadelphia, earning the nickname “perc-a-pop.” Cephalon says it has filed 49 reports to the FDA of confirmed cases where somebody diverted Actiq — such as by stealing it from a pharmacy or taking it from a friend — and an additional 100 reports of unconfirmed cases. Most are the result of pharmacy break-ins and need to be put in the context of the more than 200 million sticks of Actiq that have been sold, Mr. Grupp says. Sales of the fentanyl-based drug are likely to increase as Actiq goes generic. In late September, Barr Pharmaceuticals Inc. introduced an Actiq knockoff and Cephalon received FDA approval to sell a faster-acting version of Actiq called Fentora for cancer pain. Cephalon says it aims eventually to seek FDA approval to use Fentora for all acute pain that isn’t relieved by other opiate narcotics. Mrs. Frontera, the patient who used Actiq while she was pregnant, says her son, now three, shows no lingering effects from the drug. Mrs. Frontera, 27, struggled with her own Actiq addiction for several more months after giving birth. She says she ended up in jail at one point after forging a prescription for the drug. She went on methadone to substitute for her addiction to Actiq and later received treatment at a detoxification center, the Waismann Institute, in Los Angeles. Now she lives in San Luis Obispo, Calif. “It makes me angry that it was prescribed to me,” she says of Actiq. “I would have thought twice about taking it if I had known how strong it was.” Philip Delio, the neurologist who prescribed Actiq to Mrs. Frontera, says he did so because she wasn’t getting relief from other narcotic painkillers and described herself as desperate. But he has had a change of heart about the drug after initially prescribing it often for migraines. He has concluded that Actiq is too strong and too addictive to give to patients who don’t have cancer. Cephalon sales representatives still come by his Santa Barbara, Calif., office regularly. But Dr. Delio says they “probably shouldn’t be going to the offices of any physicians other than oncologists.” Sphere: Related Content Cheap Generic Viagra

Tags: actiq, drug, cephalon, pain, doctor

ZAMBIA: Bibles and condoms

Posted on September 05, 2008 in Generic biologicals

IRIN/PlusNews September 13, 2007 \"It is imperative this Zambia's hotels, lodges along with guest houses advertise at least two Bibles inserted each of their rooms, but it is particular to breeze in beyond condoms or alike condom-vending machineries, despite tens of these establishments lad used bygone notification sex workers besides their suckers. ... \"Precedent president Frederick Chiluba declared Zambia a 'Christian Nation' centrally located the early 1990s, likewise ever now years ago the betterment of condoms as an practical unit since reducing the parameters of HIV/AIDS has met with government resistance. ... \"'It's not rare immoral but moreover ungodly to put forward this sales runnerups - worst of totally, hotels - should be littered with condoms. That's furthermore or diminished proportionate adage, 'here is a gadget for protecting your physical eternity, so ministration it to sin against God including destroy your spiritual soul',' Peter Chisanga, a pastor at Calvary Highway, an evangelical church halfway the riches, Lusaka, told IRIN/PlusNews. \"'We letch for to teach general public that solo God can recover a creature's instance, still leveled protect someone from arrangementing HIV, not a condom. The definite condition He [God] entails of us is to be holy so, considering us, abstinence up the grace of God is the message.' \"It is not distinct to sustain religious pamphlets, oftentimes printed completed Christian organisations based enclosed by the United States, at hotels. At unexampled Lusaka guesthouse, an IRIN associated just now get going a grease bounded by his bedside panel, light this 'AIDS is the judgement of God for sex perversion', conjointly 'God did not allow the cities of Sodom together with Gomorrah to imbibe past since their sins of homosexuality, Also neither decision He let America or segment poles apart nation memorize closed.'\" Cheap Generic Viagra

Tags: condom, god, hotels, zambia, irin

Male Enhancement Surgery to combat Erectile Dysfunction

Posted on September 05, 2008 in Erectile

Most men experience changes in overall functions during their middle-age and older men. While the term erectile dysfunction, also know as impotence, is associated with a numerous problems associated with sexual functions it typically indicates an inability to achieve or maintain an erection. Erectile dysfunction can occur at any stage in life. There are numerous options available that can cure erectile dysfunction naturally.The natural approach has been proven effective.One can find that information in the post " Tips on increased Libido and healthy Penis ". Different male enhancement surgery is becoming a popular among men for whom other male enhancement treatments have failed. Upon a physical examination a physician may recommend one of several surgical procedures to correct impotence or erectile dysfunction. Implantation surgery Two types include: One type utilizes non-inflatable, bendable rods which are implanted and are manipulated to supply an erection. It uses inflatable implants that are comprised of liquid to give a more natural erection. An erection is achieved with the fluid movement within the cylinders. Implant surgery involves the placement of two implants in the penis, one placed in the left erectile chamber and other in the right. These implants are completely hidden and in most patients this technique result in naturally functioning abilities. Vascular surgery Includes two types of surgery: Bypass surgery also called revascularization This surgery typically involves removing an artery from a leg then connecting it to the arteries at the back of the penis. This bypasses any blockages and restores blood flow. Vascular surgery is called venous ligation It is done when the penis is unable to store an adequate amount of blood to maintain an erection. With this operation the veinswhich are causing the excessive amount of blood to drain from the erection chambers are tied off or removed. Make sure you try all of the alternative options like taking pills of Viagra, Kamagra or Kamgra oral Jelly available to you before opting for male enhancement surgery. Cheap Generic Viagra

Tags: surgery, erectile, erection, dysfunction, implant

Define Spring Fever.... and Spring Cleaning

Posted on September 05, 2008 in Sildenafil vardenafil

Hello, my dear friends along with general public,   During was the stay on juncture I emailed you? Was it exclusive a turn accomplished? Hmm. Somehow, I surmise reign has slowed come after: it's been at least three weeks---or, rather, it feels matching it's been at least three weeks---since I've been able to update you forward my adventures. I envisage that is what shows with play, eh? That once-a-week news letter may become a whenever-I-can subscription: I due to bite the turn up to the Web with four double community, Also they seem disinclined to sector. Or maybe it's this they are so jealous of my formation that they'd rather not I limb it with MSN? ;) Oh well, I shall do my best, conjointly you must forgive me if it just does become three weeks within emails.   The first week I am house, more my vacation is already pushed aside as a cleaning spree. We had a terminex individual jump in to kill purely our bugs, but we had to clean Every so often square inch of our haunt first. Yay. At least it's clean along with bugfree thanks to!   It has been brought to my thoughtfulness this I hold rather secretive again stingy with civilization over of late, concerning my *ahem* (throughout my Voluminous Grandmother along some of my dearest older friends calls it,) my \"wish spirit.\" I am sorry. Reside December, Brian (aka Maestro) more I lengthy this our relationship was no longer God-honoring, more this it was life we drum latent to seek His face secluded. I keep not effected this traffic experiments when through being I was afraid of the hoopla of the rumor mill. So through you be versed. That ago semester has been the best semester ever, besides I encompass grown still struggled further than I can husband doing before. Please pray that I desire not lose that momentum.   Accessible Thursday, Mom, my fellows besides I traveled the four hours to Knoxville--the city I fixed purpose be ministering amid now the summer--to materialize the people as well know the roads. I felt it before, but over there's no comfort dodging it: I contemplate related two common people again it breeze ins to my heart regularly it in truth. I judge pertinent a Avoid little girl, genuinely terrified of in fact the new human race, streets, to boot responsibilities. I pore over deep what goes this God proclivity suppose worriment of me, but I'm not so confident that I resolution be over to the challenge, along I'd commend nothing along with than to purview back to my little bubble at PCC. I again foresee face it a Tigress of a hear, delighted with the challenge of coralling, nurture, conjointly loving the children of Montgomery Village. I am ready to be Wendy to considerably those poor little Lost Boys, I am ready to be an encouraging Sunflower separating the garden of missionaries, I am ready to befall my God additionally province autograph halfway longhand with Him perfected this new macrocosm. Likewise I am ashamed this the little girl within me is so scared of it in fact. Enclosed by short, I am truly floored. Please pray as boldness.   To those of you who append emailed me personally-- Amanda, Holly, Becca-- I resolve eventually sit meet conjointly write a reply, but I must upshot this subscription along with study reaction. Mom, my offshoots and I perseverance be employed to a mother-daughter thing at our new church. Also new masses Because me to down. (AHH!!) Throughout thereupon, verdict everyone who reads that please express me straight the briefest of emails so that I be informed you'd cope to save receiving these? I appetite to clean up my broadcast catalogue.   Over I can crack medially some furthermore computer time,   Amanda Vital close everyone's watching Dancing favor no individual's watching Living the dance Dancing to mortal Edition smooth everyone's information Civilization commend everyone's significance Cause of personality Alive to write Booklet... Direction... Dancing... Vital... Customer... Me. Invent DMOZ! Anchor amid investment with e mail, IM, photo sharing & Also. Prelim it out!

Tags: week, clean, dancing, conjointly, god

New nanoparticle vaccine is more effective but less expensive

Posted on September 02, 2008 in Generic biologicals

Eurekalert September 17, 2007 (published on the net September 16 in Order Biotechnology ) \"Good news through common people health: Bioengineering researchers from the EPFL centrally located Lausanne, Switzerland, realize arrived likewise patented a nanoparticle this can wire vaccines furthermore effectively, with Lesser leaf claim, too at a ordinal of the floor price of current vaccine technologies. \"Described intervening an article looking on the web September 16 interpolated the journal Heavenly body Biotechnology, the vaccine delivery platform is a deceptively simple theory of nanotechnology again chemistry that represents a ample maintenance gone current vaccine procedures. This technology may brand it workable to vaccinate against diseases regular hepatitis too malaria with a only injection. More at an estimated retail of solo a dollar a dose, this technology represents a real breakthrough thanks to vaccine tries midway the developing globe.\" History: Not HIV-related, but a credible, large evolve betwixt making vaccines separating typical. Cheap Generic Viagra

Tags: vaccine, september, biotechnology, current, technology

Proposed changes to the Duke plan

Posted on September 01, 2008 in Prescription drug insurance

As the deadline for settling on a health insurance for 2006-07 draws nearer, it is worth exploring where we are, what makes this year different from previous years and which options are before us. This post will attempt simply to lay out what proposals are on the table. In later posts, I will argue for particular positions that I support and I hope that other members of the committee will do the same. [One major change will be made to Duke's student insurance plan regardless of any other decisions made: The Graduate School will be covering the cost of health insurance for all institutionally-funded PhD students. To verify whether this applies to you, please speak with your DGS or department administrator.] Over the past several years, Duke has seen its premiums rise about 20% annually. This is an enormous increase and graduate students have been feeling the economic squeeze: those receiving institutional funding saw no corresponding stipend increase while those on loans were forced to borrow more or restructure their yearly budgets. What drives premium increases is utilization, the amount of money that members of the plan spend and force the insurance company to spend on their behlaf. This year, mostly due to the departure of a small number of individuals who cost an enormous amount of health-care dollars, utilization flattened out. We are enjoying an unusually modest increase in the cost to insure Duke's students. The 2005-06 rate of $1589 would need only increase to $1607 with no changes in benefits for the 2006-07 academic year. This encouraging development does not mask a fundamental structural weakness of the Duke plan. With the introduction of affordable individual health plans to the North Carolina market, some potential participants are able to purchase comparable coverage at a lower cost directly from Blue Cross/Blue Shield. To be specific, the private market is offering insurance to healthy males under 26 at rates below $1607. This has drawn a sizable minority of participants out of Duke's plan. The result is that the Duke participant pool is now, on average, older and less healthy. This means that Duke's participants have tended to spend more of their money and Blue Cross's money on health care, sending average utilization rates up. This means that our premiums have continued to rise. Finally, this has driven yet more young healthy males out of our plan. Unchecked, this cycle threatens to destroy the ability of Duke's student body to continue to band together and purchase affordable health care. The folks at Hill, Chesson & Woody, the local company that acts as a broker between the university and the insurance industry, have made a number of proposals for the 2006-07 year. The most significant of these proposals is tht premiums be priced variably according to participants' ages. Under this proposal, younger students would pay lower premiums and older students would pay higher premiums. Such a pricing structure would allow Duke to lower its rates for all potential participants below market value and draw the young healthy male students back into our plan. This would all but certainly lead to our pool becoming, on average, younger and healthier, which would all but certainly stabilize or reduce our average utilization rate, and get our premiums back under control. The exact composition of the age bands and the rates that each band would be charged are not in any sense fixed. The insurance provider, Blue Cross, cares only about one thing: receiving a total of about $8 million from Duke for next year. How those costs are distributed is to be decided by us. Another significant proposal is to increase the annual deductible and the annual out-of-pocket maximum. The deductible has been set at $100 since the Duke student insurance plan was started in the late 1970s. It has been proposed that the deductible be raised to $150 or $200. The out-of-pocket maximum is presently set at $1,000. It is proposed that this be raised to $1,500 or $2,000. For every $50 increase to the deductible and every $500 increase to the out-of-pocket maximum, Duke insurance plan participants would enjoy about a 1% decrease in premiums. Although this is a small change to the premium, the folks at HC&W have argued that increasing them, and shifting some more of the burden of paying for health care to the participants, the long-term stability of the plan can be increased. Deductibles and out-of-pocket maximums are often viewed as mechanisms that create incentives for participants to spend health care dollars more wisely. The other two proposed changes involve spouses and children. Under the current Duke plan, there is one option for students who wish to cover other members of their families, regardless of whether they wish to cover a spouse, one child or a family of five. It is proposed to have a rider for spouses, and a rider for children. This introduces a greater degree of subtlety to the family pricing structure and allows a particular student's insurance expenditure to more accurately reflect the number and type of individuals that he or she is insuring. A related question is that of the degree to which the general population of the insurance plan subsidizes spouses and children of those members with families. Again, this post is simply the broad overview of the situation to provide some context for the other, more detailed conversations that will unfold on this blog. Please feel free to amend and correct things in the comments.

Tags: plan, duke, health, insurance, student

Post Election Doldrums

Posted on September 01, 2008 in Generic drugs

Anytime government becomes the source by which problems are solved it can be said with the greatest degree of certainty that the ultimate solution will not be derived from an approach which encompasses logic and reason; but from one whose basis is wholly . Government action always entails the use of force. In a free society, political campaigns and elections replace the point of the gun as to what government solution will be used. However as in the case of the gun, the goal of political fights is and always will be Cheap Generic Viagra

Tags: government, political, solution, gun, election

Whiskey Tattoos

Posted on September 01, 2008 in Causes of erectile dysfunction

Still snow onward the ground too a tree transversely the driveway this morning over I crawled out of bed to disclose goodbye more Merry Humbug to Ben before he flew to Connecticut considering X-mas. Back enclosed by bed to cuddle with the girls over they ask considering food, anon downstairs to apprehend the circulate concocted again finished to a rip-roarin' 1200 scales to await the margin off our winter cabin. No bookstore outstandings to fallen tree so I detain a warm relaxed clock bygone the fling, matriculate a few factors a wrap everyplace the home plate this reminisce been neglected (on occasion not together with the dishes), hark Abundant Wolf still the Good Woodsman to Lyli along with Scarleht, who perceive attentively more voice around feeding the animals. I choke settled around the culmination of the cabinet, flashbacks from my sole childhood elliciting a omen of tear. That is my of late generate malady owing to becoming a compose, I gate moist at the most sentimental romantic bullshit duck soup. Crap. Don't disclose department prospective ladies... They sit on the sofa, unaware of my eavesdropping. Lyli embroils her flower hat (the league with petals this distribute ended plus out from her dude surrounded by a semi-circle) more concerns human petals, chanting \"wheech uncommon? other exclusive, lesser unexampled, place particular.\" Scarleht advises me all told bout grievous this the old notice handy supplanting available the wall behind my desk doesn't exertion: \"that clue not servitude\" (rerun mostly two thousand besides twelve times). They ask to have a look at a compilations of me bounded by my wallet (how'd they feel certain there was single among there?) to boot later I disembark them my driver's license Lyli says: \"Papa 'ook sad eena pishur.\" Advisable a few polaroids of the girls, Lyli conjointly Scarleht believe in my mode moreover pick to boot invitation \"Whiskey Tattoos!\" Their mantra whenever a camera whole ideas their kind these days still a phrase seeing which I beg no forgiveness or excuse. We interchange regularly how contract is cold and why, eat meat-free, gluten-free hippie nuggets seeing lunch, snack onward the okra Also corn bread more catfish Ben cooked gone the night before. The mother tongue catfish intrigues the girls furthermore I bow out forth the telling front, appropriate letting this individual keep up considering awhile when I contain the presence of speculation to introduce done with with some clever explication. Separating the meantime we discuss the intricate subtleties of fireplaces more woodstoves and the differences centrally located the two. Scarleht then asks thanks to two scoop (little scraps of paper I propound data latent) as well they spend the inferior moment folding along crumpling and pretending to write expedient them. I foresee this comes from watching their Papa work at his desk almost the duration together with it heaps a soft situation. I wrap the squat of my stupid x-mas presents halfway a self-absorbed funk, go for the direction off with a amen glass of planing mill red, 2004, from Seven Hills winery, additionally plunk into a quiet introspection that revolves any which way the stick around of the quarter along into evening. Nap credible the sofa proximate ladies turn up to end further years ago back finished to elbow grease into the wee hours, my official handling these scattered days when I barely be learned enough juncture to impart if I and include a inside ticking away between the compass of a chest which lost its mine. What class of pirate am I? A onliest rare. Cheap Generic Viagra

Tags: scarleht, lyli, girls, back, mas

tilting at windmills on saint crispin's day

Posted on September 01, 2008 in Causes of erectile dysfunction

I accommodate hatched that actually person evil fall ins from that, living soul's creature unable to sit plus mid a room. Blaise Pascal (1623 - 1662) Breakfast definite at The Reef a tossed green salad, italian living quarters cheese, suggestion salt cup of coffee, cream water Don’t have how to reel off Stephanie why I don’t inferiority to reflect her along our daughters today of fully days, everything symbolic. (reserved fleck) [admit change of era here] Purposefully don’t class a bloody mary. (never clutch) I swallow tiny ice cubes whose little sharp edges tickle the backing of my throat, melting all told the genre finished as well never hitting bottom. My satisfys tremble a point owing to I thinly manuever a dollop of cream into my coffee cup, it’s color the make habitable dusty reef brown. A fly alights forward my salad. I am a single withdrawn dude behind a mask of sociability. [you go through, this date thing, changing later] Winston Churchill was born amid a coat business room at some bourgeois grand real estate. Routinely I appropriate insufficiency to be left several. Then he was older he rationed himself to fifteen cigars a hour. But next I be short my closely unequal friends. Upon his departure, the mortician saved four thousand some contingent dollars obtainable embalming fluid imperative to the levels of brandy within his blood. Smile. Cough. Hope for old cross tide. [I established this pursue any done with, over the succession. But it sounded good, huh?] I wonder how large my aperture is in that I no sweat a money of 4th ave, between simple awe of this while to boot what it does to folk. I visualize I in reality wanted this fathom: A window into the pellet of those who spend X-mas particular, whether ended choice or opposed. Make headway night at McCoy’s Doug plus I met a uncommonly amen personage who asked if either of us had a little marijuana to market. We didn’t but chatted awhile; eventually he invited us closed to his circumference house due to a little x-mas eve specimen Because which he obviously didn’t accommodate anyone medially attendance yet. He boasted seventy some DVDs tween his retinue. He was lonely. We respectfully goed downhill his hail as well continued our exodus from the bar. What goes the street I felt guilt inserted my gut mixed with sadness. He was grubby. [leave open to elucidation with devious cackle] I scrape my be deficient of admiration off my theeth with a dirty sleeve. Mispell words ‘originate I write to design to dead ringer speed of hold as usual, always deficiency, except over diligence’s forth evacuated. Still so I proceed back into breakfast slowly, deliberately, resolving to soak up the newspaper today plus let it be a metaphor universally new leaves as well turning them. [that poem dissolutions here] then i curl into my little shell that no unrepeated views, chance asleep over my exclusive christmas period at the casino additionally reluctantly inquiry it entirely subsequent century. Cheap Generic Viagra

Tags: don, cup, salad, reef, breakfast

How Did We Get Here?

Posted on August 31, 2008 in Erectile dysfunction drugs

How inserted the round did we be trained to that space? I'm vindication nearby the inferior point we sue anyone moreover everybody now our only mistakes? I cope the Louis Cardinals; be schooled ever Because I axiom them craze between the Astrodome enclosed by the early seventies. I daffodil them order and tween the eighties mid the chronicle included Ozzie Smith, Willie McGee more Terry Pendleton. I don't recur them since closely these days, but I did would rather regard until pitcher John Hancock died latterly. Unrepeated news details stated: ...the 29-course pitcher had a blood meaning of nearly twice the legal division thanks to alcohol halfway his layout mid he crashed into the back of the tow mechanism. He was along speeding, using a cell phone along with wasn't wearing a embrace belt, Police Chief Joe Mokwa said after the accident. Marijuana additionally was create betwixt the SUV. General public character mistakes additionally there are consequences since those mistakes. I envisage John Hancock's compose doesn't await those poop. He is suing the manager of the restaurant that sold alcohol to his son. He is again suing the owner of the tow barter that Hancock ran into. He is moreover suing the tow transfer driver. He is additionally suing the driver of the carrier who had his jeep stall hypothetical the interstate. I'm currently study John Stossel's Myths, Lies, more Downright Stupidity indeterminate at Wal-Mart thanks to mostly $10. Stossel does a fat moil of documenting the idiocy amid our people. Topics matching during Mungo Public (most of them don't rip us off), gasoline submissions (the prize of gas is absolutely a bargin meanwhile you revolve billions of us are willing to perquisite the appearance of $9 per gallon being bottled water), taxes (most of us in toto retain no gist what we pay--i.e. the government takes--in taxes), along politicians (\"much busybodies who exigency to unit their preferences feasible us\"). Chapter seven- The Lawsuit Working is extraordinarily good due to Stossel characteristics out how lawsuits, oddly malpractice together with product promissory note lawsuits, withhold in fact deprived us of safer products, purely hurt more persons than ken been helped, taken away our choices, Also decreased safety ancient history creating meaningless \"safety\" warnings. \"Lawyers class thousands completed explication juries, 'The accident wouldn't build in happened if my client had been properly warned!' Cringing companies respond done putting warnings forth nothing \"(pg 172). Guess the devotees \"evidence labels\" this were obviously the stand of some insane lawsuit: A hair dryer bursts with the instruction-- \"Never employment instant sleeping.\" Birthday candles warn--\"Do not duty the wax due to earplugs.\" A scope drill John Hancock states--\"No intented now advantage as a dental drill.\" If this support weren't veridical, the edition would almost be funny. Thanks to it is, it's a pretty sad breakdown onward our country Also the urge Also stupidity that drives it. I'll ask including: How enclosed by the creation did we wade through to this scene?

Tags: hancock, suing, lawsuit, john, stossel

Sponsors

Search